AZN vs. IGM.TO
AZN (AstraZeneca PLC) and IGM.TO (IGM Financial Inc.) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while IGM.TO operates in Asset Management (Financial Services). Over the past 10 years, AZN returned 15.97%/yr vs 13.96%/yr for IGM.TO. At a 0.23 correlation, their price movements are largely independent.
Performance
AZN vs. IGM.TO - Performance Comparison
Loading charts...
Different Trading Currencies
AZN is traded in USD, while IGM.TO is traded in CAD. To make them comparable, the IGM.TO values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN achieves a -0.75% return, which is significantly lower than IGM.TO's 28.79% return. Over the past 10 years, AZN has outperformed IGM.TO with an annualized return of 15.97%, while IGM.TO has yielded a comparatively lower 13.96% annualized return.
AZN
- 1D
- -1.94%
- 1M
- -4.78%
- YTD
- -0.75%
- 6M
- 1.57%
- 1Y
- 22.51%
- 3Y*
- 8.94%
- 5Y*
- 11.28%
- 10Y*
- 15.97%
IGM.TO
- 1D
- -0.01%
- 1M
- 2.66%
- YTD
- 28.79%
- 6M
- 33.11%
- 1Y
- 87.53%
- 3Y*
- 30.59%
- 5Y*
- 15.40%
- 10Y*
- 13.96%
AZN vs. IGM.TO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | -0.75% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
IGM.TO IGM Financial Inc. | 28.79% | 47.72% | 28.02% | 0.72% | -17.24% | 39.23% | 2.41% | 33.22% | -30.91% | 30.91% |
Correlation
The correlation between AZN and IGM.TO is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jul 12, 2006 | 0.23 |
Fundamentals
AZN:
$279.03B
IGM.TO:
CA$18.98B
AZN:
$6.66
IGM.TO:
CA$4.86
AZN:
26.85
IGM.TO:
16.56
AZN:
0.04
IGM.TO:
3.09
AZN:
4.62
IGM.TO:
4.96
AZN:
5.90
IGM.TO:
2.12
AZN:
$60.44B
IGM.TO:
CA$3.84B
AZN:
$49.37B
IGM.TO:
CA$1.57B
AZN:
$20.47B
IGM.TO:
CA$1.66B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. IGM.TO — Risk / Return Rank
AZN
IGM.TO
AZN vs. IGM.TO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and IGM Financial Inc. (IGM.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AZN | IGM.TO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.94 | ||
| Sortino ratioReturn per unit of downside risk | -3.33 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.67 | -0.49 |
| Calmar ratioReturn relative to maximum drawdown | 1.47 | 7.90 | -6.43 |
| Martin ratioReturn relative to average drawdown | 3.82 | 34.53 | -30.71 |
Loading charts...
Drawdowns
AZN vs. IGM.TO - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum IGM.TO drawdown of -64.73%. Use the drawdown chart below to compare losses from any high point for AZN and IGM.TO.
Loading charts...
Drawdown Indicators
| AZN | IGM.TO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -64.73% | +15.79% |
Max Drawdown (1Y)Largest decline over 1 year | -15.43% | -11.14% | -4.29% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -29.04% | +1.17% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -39.23% | +11.36% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | -53.98% | +26.11% |
Current DrawdownCurrent decline from peak | -14.25% | -1.28% | -12.97% |
Average DrawdownAverage peak-to-trough decline | -11.37% | -20.46% | +9.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.99% | 2.54% | +3.45% |
Volatility
AZN vs. IGM.TO - Volatility Comparison
AstraZeneca PLC (AZN) has a higher volatility of 7.95% compared to IGM Financial Inc. (IGM.TO) at 6.12%. This indicates that AZN's price experiences larger fluctuations and is considered to be riskier than IGM.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | IGM.TO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.95% | 6.12% | +1.83% |
Volatility (6M)Calculated over the trailing 6-month period | 17.74% | 19.15% | -1.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.76% | 23.02% | +2.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.03% | 22.16% | +1.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.93% | 23.71% | +1.22% |
Dividends
AZN vs. IGM.TO - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.98%, more than IGM.TO's 2.87% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.98% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
IGM.TO IGM Financial Inc. | 2.87% | 3.64% | 4.90% | 6.43% | 5.96% | 4.93% | 6.52% | 6.04% | 7.25% | 5.14% | 5.91% | 8.07% |
Financials
AZN vs. IGM.TO - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and IGM Financial Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. IGM.TO - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
IGM.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IGM Financial Inc. reported a gross profit of 509.55M and revenue of 925.05M. Therefore, the gross margin over that period was 55.1%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
IGM.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IGM Financial Inc. reported an operating income of 330.21M and revenue of 925.05M, resulting in an operating margin of 35.7%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
IGM.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IGM Financial Inc. reported a net income of 283.82M and revenue of 925.05M, resulting in a net margin of 30.7%.
Frequently Asked Questions
AZN and IGM.TO have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN and IGM.TO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer